Taken together, they represent new tools to manipulate and to study the PP1/LRRK2 interaction under normal and pathological conditions with the immediate perspective to analyze the potential of these peptides in vivo in appropriated mouse models of PD. The gene discussed is LRRK2; the disease is Parkinson disease.